UPDATED Apr 26, 2024
Stocks with high levels of insider buying the past 3 months and good analyst coverage.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
CYAN | US$0.30 | -14.4% | -69.1% | US$2.1m | n/a | PB0.2x | n/a | n/a | Household | ||
CNEY | US$0.79 | 10.9% | -87.5% | US$2.1m | n/a | PB0.02x | n/a | n/a | Materials | ||
INM | US$0.23 | -20.7% | -80.8% | US$1.4m | n/a | PB0.1x | S15.7% | n/a | Pharmaceuticals & Biotech | ||
BSPK | US$0.092 | -15.8% | -37.9% | US$940.6k | n/a | PS1.2x | n/a | n/a | Pharmaceuticals & Biotech | ||
SHPN.F | US$0.03 | 0% | -62.3% | US$856.2k | n/a | PS16.1x | n/a | n/a | Energy | ||
LUPG.F | US$0.004 | 0% | n/a | US$824.3k | n/a | PB0.02x | n/a | n/a | Software | ||
GMPW | US$0.017 | -29.4% | -65.4% | US$735.7k | n/a | PE-18.1x | n/a | n/a | Software | ||
BTTX | US$0.01 | 61.3% | -99.1% | US$545.2k | US$1.50 | PE-0.02x | E-40.6% | n/a | Healthcare | ||
IGOT | US$0.0048 | 1.1% | -88.0% | US$515.5k | n/a | PE-0.4x | n/a | n/a | Commercial Services | ||
RMES.F | US$0.005 | 0% | -88.9% | US$274.3k | n/a | PE-0.4x | n/a | n/a | Materials | ||
HMLA | US$0.0007 | 40.0% | -46.2% | US$213.5k | n/a | PE-0.3x | n/a | n/a | Media | ||
VRSE.F | US$0.0023 | -54.0% | n/a | US$101.1k | n/a | PB11x | n/a | n/a | Healthcare | ||
SIRC | US$0.0002 | -33.3% | -100.0% | US$5.0k | n/a | n/a | n/a | n/a | Capital Goods |